MC

489.6

+4.44%↑

SANES

7.105

+1.98%↑

ALV

341.3

-0.61%↓

BNP

76.59

+2.02%↑

BBVA

13

+1.4%↑

MC

489.6

+4.44%↑

SANES

7.105

+1.98%↑

ALV

341.3

-0.61%↓

BNP

76.59

+2.02%↑

BBVA

13

+1.4%↑

MC

489.6

+4.44%↑

SANES

7.105

+1.98%↑

ALV

341.3

-0.61%↓

BNP

76.59

+2.02%↑

BBVA

13

+1.4%↑

MC

489.6

+4.44%↑

SANES

7.105

+1.98%↑

ALV

341.3

-0.61%↓

BNP

76.59

+2.02%↑

BBVA

13

+1.4%↑

MC

489.6

+4.44%↑

SANES

7.105

+1.98%↑

ALV

341.3

-0.61%↓

BNP

76.59

+2.02%↑

BBVA

13

+1.4%↑

Corbion NV

Затворен

СекторФинансови

18.58 1.25

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

18.26

Максимум

18.66

Ключови измерители

By Trading Economics

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+31.94% upside

Дивиденти

By Dow Jones

Следващи печалби

31.07.2025 г.

Настроения в новините

By Acuity

50%

50%

192 / 538 Класиране в Finance

Corbion NV Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

1.07.2025 г., 23:09 ч. UTC

Печалби

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

1.07.2025 г., 19:16 ч. UTC

Придобивния, сливания и поглъщания

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

1.07.2025 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

1.07.2025 г., 23:41 ч. UTC

Пазарно говорене

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

1.07.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

James Hardie: Deal Represents Implied Value of $8.4 Billion

1.07.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

1.07.2025 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

James Hardie Completes Acquisition of AZEK

1.07.2025 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

1.07.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

1.07.2025 г., 20:24 ч. UTC

Печалби

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

1.07.2025 г., 19:55 ч. UTC

Пазарно говорене

Oil Futures Resume Cautious Rally -- Market Talk

1.07.2025 г., 19:27 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Lose More Ground -- Market Talk

1.07.2025 г., 19:12 ч. UTC

Пазарно говорене

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

1.07.2025 г., 19:01 ч. UTC

Придобивния, сливания и поглъщания

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

1.07.2025 г., 18:41 ч. UTC

Придобивния, сливания и поглъщания

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

1.07.2025 г., 18:33 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

1.07.2025 г., 18:33 ч. UTC

Пазарно говорене

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

1.07.2025 г., 18:32 ч. UTC

Пазарно говорене

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

1.07.2025 г., 18:22 ч. UTC

Пазарно говорене

Remittances to Mexico Down in May -- Market Talk

1.07.2025 г., 17:45 ч. UTC

Пазарно говорене

Seasonal Demand Supports Further Oil Gains -- Market Talk

1.07.2025 г., 17:01 ч. UTC

Придобивния, сливания и поглъщания

Danone Completed Acquisition of Majority Stake in Kate Farms

1.07.2025 г., 16:55 ч. UTC

Печалби

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

1.07.2025 г., 16:27 ч. UTC

Пазарно говорене

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

1.07.2025 г., 16:25 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

1.07.2025 г., 16:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

1.07.2025 г., 15:48 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

1.07.2025 г., 15:46 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

1.07.2025 г., 15:46 ч. UTC

Пазарно говорене

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

1.07.2025 г., 14:54 ч. UTC

Пазарно говорене

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

1.07.2025 г., 14:49 ч. UTC

Пазарно говорене

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Corbion NV Прогноза

Ценова цел

By TipRanks

31.94% нагоре

12-месечна прогноза

Среден 24.33 EUR  31.94%

Висок 33 EUR

Нисък 16 EUR

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Corbion NV през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

3 ratings

2

Купи

0

Задържане

1

Продай

Настроение

By Acuity

192 / 538 Класиране в Финансови

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Corbion NV

Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands.